Longevity Health HoldingsXAGE -23.30%6 EBIT per Share is $-4.28 as of Mar. 2026. GuruFocus rates XAGE with a GF Score™ of 6/100. The stock has 3 warning signs investors should review. Among 1,581 Consumer Packaged Goods companies, Longevity Health Holdings ranks better than 64.33% on this metric.
Longevity Health Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was $-0.75.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.28.
During the past 3 years, the average EBIT per Share Growth Rate was 16.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Longevity Health Holdings's EBIT per Share or its related term are showing as below:
XAGE'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -32.4 Med: -7.85 Max: 16.7
Current: 16.7
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Longevity Health Holdings was 16.70% per year. The lowest was -32.40% per year. And the median was -7.85% per year.
XAGE's 3-Year EBIT Growth Rate is ranked better than 64.33% of 1581
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs XAGE: 16.70
Longevity Health Holdings (OTCPK:XAGE) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Longevity Health Holdings EBIT per Share Related Terms
Longevity Health Holdings EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.28
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Longevity Health Holdings (XAGE) has a EBIT per Share of $-4.28 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Longevity Health Holdings and its competitors. According to the industry distribution chart, Longevity Health Holdings ranks #564 out of 1581 companies in the Consumer Packaged Goods industry, placing it in the top 35.7%.
Is Longevity Health Holdings' EBIT per Share too high?
Longevity Health Holdings' current EBIT per Share is $-4.28. Based on the distribution chart, Longevity Health Holdings ranks #564 out of 1581 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Longevity Health Holdings has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Longevity Health Holdings' EBIT per Share compare to SNBH and SKVI?
According to the Consumer Packaged Goods industry distribution chart, Longevity Health Holdings ranks #564 out of 1581 companies for EBIT per Share. This puts Longevity Health Holdings in the upper half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Longevity Health Holdings and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Health Holdings's current EBIT per Share is $-4.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Health Holdings stock overvalued right now?
Longevity Health Holdings (XAGE) has a current EBIT per Share of $-4.28. The current EBIT per Share is $-4.28. Longevity Health Holdings' overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Longevity Health Holdings (XAGE), the current EBIT per Share is $-4.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Longevity Health Holdings Inc is a bio-aesthetics company focused on longevity and healthy aging. The company develops cosmetic skincare and haircare products designed to support skin and hair health, tailored to meet the technical requirements of professional care providers as well as retail consumers. Its product pipeline also includes regenerative bone and tissue healing solutions, although further research and development in this area has been paused. The company markets its cosmetic products in the United States through business-to-business, direct-to-consumer, and distributor sales channels.
6GF Score
Get the complete analysis for XAGE
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XAGE has been successfully added to your 
